symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
NVCT,9.53,0,43337,164214289,0,6.21-18.65,-1.2,"Nuvectis Pharma, Inc.",USD,0001875558,US67080T1088,67080T108,NASDAQ Capital Market,NASDAQ,Biotechnology,https://www.nuvectis.com,"Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.",Mr. Ron  Bentsur M.B.A.,Healthcare,US,11,201 614 3150,1 Bridge Plaza,Fort Lee,NJ,07024,,0,https://financialmodelingprep.com/image-stock/NVCT.png,2022-02-04,False,False,True,False,False
